- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
Sonoma Pharmaceuticals (Nasdaq:SNOA), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today launched a new and improved Acuicyn Antimicrobial Eyelid and Eyelash Hygiene solution. As quoted in the press release: “I’ve recently switched over from using Avenova to Acuicyn because Sonoma …
Sonoma Pharmaceuticals (Nasdaq:SNOA), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today launched a new and improved Acuicyn Antimicrobial Eyelid and Eyelash Hygiene solution.
As quoted in the press release:
“I’ve recently switched over from using Avenova to Acuicyn because Sonoma is the original U.S. medical-grade hypochlorous acid company with a wide range of products that have helped patients across many therapeutic indications around the globe,” said Dr. Mary Boname OD, MS, FAAO, and president/owner at Montgomery Eye Care. “I could not be happier with the results. Not only are my patients satisfied with cleaner and clearer eyes, Acuicyn’s cost is significantly less than the cost of Avenova. I was pleased with Avenova, but I’m beyond thrilled with Acuicyn!”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.